Berenberg keeps EUR 3.60 target for Evotec stock

Published on 10/27/2026 at 10:25 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evotec reported EUR 465.0 million for nine months of 2026. Evotec stock costs EUR 2.84 on October 27, 2026, 1.43 percent above Xetra close.

Evotec's latest signals

Berenberg kept its Neutral rating and EUR 3.60 target on October 16, 2026.
Preliminary nine-month revenue reached EUR 465.0 million on October 13, 2026.
Evotec stock trades at EUR 2.84 at 10:14 a.m. CET at Lang & Schwarz on October 27, 2026, 1.43 percent above the Xetra close of October 26, 2026.

Evotec SE, DE0005664809, Illustration mit AI erstellt.

Evotec (ISIN DE0005664809) stock was trading at EUR 2.84 at Lang & Schwarz on October 27, 2026, at 10:14 a.m. CET, up 1.43 percent versus the Xetra close of October 26, 2026. On October 16, 2026, MarketScreener reported that Berenberg kept its Neutral rating and EUR 3.60 price target for Evotec.

Three recent markers

On October 13, 2026, Evotec announced preliminary revenue of EUR 465.0 million for the first nine months of 2026 and adjusted EBITDA of minus EUR 42.8 million, according to Stockwatch. The company also reaffirmed full-year revenue guidance of EUR 570 million to EUR 610 million.

On October 15, 2026, Deutsche Bank kept a Neutral rating and a EUR 3.50 target, according to MarketScreener. One day later, Berenberg retained Neutral and its EUR 3.60 target, giving investors two cautious reference points below the wider analyst range.

What does the target say?

Berenberg's EUR 3.60 target lies 26.76 percent above the EUR 2.84 Lang & Schwarz price. That comparison is more restrained than RBC's EUR 10.00 target, which MarketScreener said was maintained on October 14, 2026 after preliminary results exceeded expectations. The gap between these targets makes the November report important for judging whether the revenue trajectory can support a recovery in profitability.

Next reporting date

Evotec is scheduled to publish its complete third-quarter and nine-month results on November 5, 2026, according to Boerse Express. The release should clarify how the preliminary EUR 465.0 million revenue figure translates into the full-year guidance range.

Stock stays below key targets

Evotec's EUR 502.9 million market capitalization and its EUR 2.41 to EUR 7.30 52-week range put the current quote near the lower part of its annual band. The stock was trading at EUR 2.84 at Lang & Schwarz on October 27, 2026, at 10:14 a.m. CET, 1.43 percent above the Xetra close of October 26, 2026 at EUR 2.80. The further course of trading is shown by the continuously updated real-time quote of Evotec stock.